{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:59:27Z","timestamp":1792511967977,"version":"4.5.0"},"reference-count":38,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Congenital hyperinsulinism (CHI) causes severe and recurrent hypoglycemia with a 33% to 50% risk of neurodisability necessitating rigorous glucose monitoring. Continuous glucose monitoring (CGM) is now widely used in CHI with limited data on user-reported benefits. There are no validated instruments available to assess the impact of CGM use on quality of life (QOL) in CHI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate CGM user satisfaction of patients with CHI and their carers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Modified CGM-satisfaction (CGM-SAT) and glucose monitoring surveys (GMS) were distributed electronically to CHI families using CGM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>CHI highly specialized services, UK, May to August 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients or Other Participants<\/jats:title>\n                    <jats:p>Parents (n = 86) and teachers (n = 15) of patients with CHI using CGM (0-18 years old) and patients themselves if \u22657 years old (n = 20).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcome Measures<\/jats:title>\n                    <jats:p>User-reported ease of CGM handling, influence of CGM on CHI management and QOL, and desire for continued use of CGM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most respondents reacted positively to statements regarding: CGM device handling (58% agreed or strongly agreed), influence on CHI management (70%), QOL (75%), and continued use (86%). Satisfaction with CGM was positively correlated with duration of use (r = 0.40, P &amp;lt; 0.001). Eighty-six percent of users reported checking the CGM 1 to 5 times per hour. Users reported perceived improvements in safety, hypoglycemia detection, freedom, and independence, despite concerns with accuracy and device range.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patients with CHI and their carers reported that they feel safer and perceive benefits from CGM in all aspects of living with CHI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaf313","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T07:32:11Z","timestamp":1748158331000},"page":"139-148","source":"Crossref","is-referenced-by-count":4,"title":["Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A National User-satisfaction Survey, UK"],"prefix":"10.1210","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8095-7366","authenticated-orcid":false,"given":"Helen","family":"Couch","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Cambridge University Hospitals NHS Foundation Trust , Cambridge, CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pearson","sequence":"additional","affiliation":[{"name":"Quality and Safety Team, Great Ormond Street Hospital for Children NHS Foundation Trust , London, WC1N 3JH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9356-2227","authenticated-orcid":false,"given":"Neha","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Basildon University Hospital , Essex, SS16 5NL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ferguson","sequence":"additional","affiliation":[{"name":"Your Path Solutions , Toronto, ON, M6S2Y1 ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-9277","authenticated-orcid":false,"given":"George","family":"Couch","sequence":"additional","affiliation":[{"name":"Department of Anaesthetics, Cambridge University Hospitals NHS Foundation Trust , Cambridge, CB2 0QQ ,","place":["UK"]},{"name":"Department of Oncology, Cancer Research UK \u2013 Cambridge Institute , Cambridge, CB2 0RE ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4426-1045","authenticated-orcid":false,"given":"Clare","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust , London, WC1N 3JH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust , London, WC1N 3JH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Mann","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust , London, WC1N 3JH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Cassidy","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Alder Hey Children\u2019s Hospital , Liverpool, L14 5AB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Worthington","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital , Manchester, M13 9WL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"O'Shea","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital , Manchester, M13 9WL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"SalomonEstebanez","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital , Manchester, M13 9WL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6609-2735","authenticated-orcid":false,"given":"Chris","family":"Worth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital , Manchester, M13 9WL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil","family":"Senniappan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Alder Hey Children\u2019s Hospital , Liverpool, L14 5AB ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4280-7470","authenticated-orcid":false,"given":"Indraneel","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology, Royal Manchester Children\u2019s Hospital , Manchester, M13 9WL ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6332-3136","authenticated-orcid":false,"given":"Antonia","family":"Dastamani","sequence":"additional","affiliation":[{"name":"Department of Paediatric Endocrinology and Diabetes, Great Ormond Street Hospital for Children NHS Foundation Trust , London, WC1N 3JH ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"issue":"2","key":"2025121807432071700_dgaf313-B1","doi-asserted-by":"crossref","first-page":"e0228417","DOI":"10.1371\/journal.pone.0228417","article-title":"Using referral rates for genetic testing to determine the incidence of a rare disease: the minimal incidence of congenital hyperinsulinism in the UK is 1 in 28,389","volume":"15","author":"Yau","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"2025121807432071700_dgaf313-B2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13023-018-0867-6","article-title":"The burden of congenital hyperinsulinism in the United Kingdom: a cost of illness study","volume":"13","author":"Eljamel","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2025121807432071700_dgaf313-B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13023-022-02214-y","article-title":"Congenital hyperinsulinism in infancy and childhood: challenges, unmet needs and the perspective of patients and families","volume":"17","author":"Banerjee","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"2025121807432071700_dgaf313-B4","first-page":"1231043","article-title":"Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus","volume":"14","author":"Guftar","year":"2023","journal-title":"Front Endocrinol Sec Pediatric Endocrinology"},{"key":"2025121807432071700_dgaf313-B5","doi-asserted-by":"crossref","first-page":"886552","DOI":"10.3389\/fendo.2022.886552","article-title":"Congenital hyperinsulinism international: a community focused on improving the lives of people living with congenital hyperinsulinism","volume":"13","author":"Raskin","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025121807432071700_dgaf313-B6","volume-title":"HI Global Registry 2021 Annual Report","author":"Pasquini","year":"2021"},{"key":"2025121807432071700_dgaf313-B7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpeds.2019.10.068","article-title":"Health outcomes of parents of children with chronic illness: a systematic review and meta-analysis","volume":"218","author":"Cohn","year":"2020","journal-title":"J Pediatr"},{"key":"2025121807432071700_dgaf313-B8"},{"key":"2025121807432071700_dgaf313-B9"},{"key":"2025121807432071700_dgaf313-B10","volume-title":"Endotext","author":"Reddy","year":"2000"},{"key":"2025121807432071700_dgaf313-B11","doi-asserted-by":"crossref","first-page":"1116864","DOI":"10.3389\/fendo.2023.1116864","article-title":"Continuous glucose monitoring for children with hypoglycaemia: evidence in 2023","volume":"14","author":"Worth","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121807432071700_dgaf313-B12","doi-asserted-by":"crossref","first-page":"1016072","DOI":"10.3389\/fendo.2022.1016072","article-title":"The hypoglycaemia error grid: a UK-wide consensus on CGM accuracy assessment in hyperinsulinism","volume":"13","author":"Worth","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121807432071700_dgaf313-B13","doi-asserted-by":"crossref","first-page":"110895","DOI":"10.1016\/j.diabres.2023.110895","article-title":"Satisfaction with continuous glucose monitoring is positively correlated with time in range in children with type 1 diabetes","volume":"204","author":"Marigliano","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2025121807432071700_dgaf313-B14","doi-asserted-by":"crossref","first-page":"e15307","DOI":"10.1111\/dme.15307","article-title":"Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type","volume":"41","author":"Franceschi","year":"2024","journal-title":"Diabet Med"},{"key":"2025121807432071700_dgaf313-B15"},{"key":"2025121807432071700_dgaf313-B16"},{"issue":"4","key":"2025121807432071700_dgaf313-B17","first-page":"193","article-title":"Real-time glucose sensors in children and adolescents with type-1 diabetes","volume":"70","author":"Danne","year":"2008","journal-title":"Horm Res"},{"issue":"4","key":"2025121807432071700_dgaf313-B18","doi-asserted-by":"crossref","first-page":"bvad021","DOI":"10.1210\/jendso\/bvad021","article-title":"Paediatric society and hyperinsulinism charity national surveys on CGM access for patients with recurrent hypoglycaemia","volume":"7","author":"Ng","year":"2023","journal-title":"J Endocr Soc"},{"issue":"9","key":"2025121807432071700_dgaf313-B19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/dia.2010.0015","article-title":"Validation of measures of satisfaction with and impact of continuous and conventional glucose monitoring","volume":"12","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"2025121807432071700_dgaf313-B20","doi-asserted-by":"crossref","first-page":"e26957","DOI":"10.2196\/26957","article-title":"Clustering of hypoglycemia events in patients with hyperinsulinism: extension of the digital phenotype through retrospective data analysis","volume":"23","author":"Worth","year":"2021","journal-title":"J Med Internet Res"},{"key":"2025121807432071700_dgaf313-B21","author":"Randall"},{"issue":"12","key":"2025121807432071700_dgaf313-B22","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1515\/jpem-2021-0414","article-title":"The utility of continuous glucose monitoring systems in the management of children with persistent hypoglycaemia","volume":"34","author":"Vijayanand","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2025121807432071700_dgaf313-B23","doi-asserted-by":"publisher","DOI":"10.1177\/19322968241255842","article-title":"Continuous glucose monitoring\u2013derived glycemic phenotyping of childhood hypoglycemia due to hyperinsulinism: a year-long prospective nationwide observational study","author":"Worth","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2025121807432071700_dgaf313-B24","doi-asserted-by":"crossref","first-page":"894559","DOI":"10.3389\/fendo.2022.894559","article-title":"Families\u2019 experiences of continuous glucose monitoring in the management of congenital hyperinsulinism: a thematic analysis","volume":"13","author":"Auckburally","year":"2022","journal-title":"Front Endocrinol"},{"key":"2025121807432071700_dgaf313-B25","doi-asserted-by":"publisher","DOI":"10.17632\/fh3ny8h4hz.1","article-title":"Supplementary data for Continuous glucose monitoring in the management of congenital hyperinsulinism: a national user-satisfaction survey, UK.","author":"Couch","year":"2025","journal-title":"Mendeley Data"},{"issue":"9","key":"2025121807432071700_dgaf313-B26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/dia.2019.0142","article-title":"Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes","volume":"21","author":"Hilliard","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"2025121807432071700_dgaf313-B27","author":"Ahmad"},{"key":"2025121807432071700_dgaf313-B28","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fendo.2013.00060","article-title":"Abnormal neurodevelopmental outcomes are common in children with transient congenital hyperinsulinism","volume":"4","author":"Avatapalle","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"13","key":"2025121807432071700_dgaf313-B29","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.3390\/ijms241310697","article-title":"Contact dermatitis to diabetes medical devices","volume":"24","author":"Cicho\u0144","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025121807432071700_dgaf313-B30","doi-asserted-by":"crossref","first-page":"110922","DOI":"10.1016\/j.diabres.2023.110922","article-title":"High incidence of skin reactions secondary to the use of adhesives in glucose sensors or insulin pumps for the treatment of children with type 1 diabetes","volume":"204","author":"Gen\u00e8ve","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"2025121807432071700_dgaf313-B31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/archdischild-2024-327322","article-title":"Neonatal hyperinsulinism: a retrospective study of presentation and management in a tertiary neonatal intensive care unit in the UK","volume":"110","author":"Kalogeropoulou","year":"2025","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2025121807432071700_dgaf313-B32","doi-asserted-by":"crossref","first-page":"1115228","DOI":"10.3389\/fped.2023.1115228","article-title":"Should continuous glucose monitoring be used to manage neonates at risk of hypoglycaemia?","volume":"11","author":"Kalogeropoulou","year":"2023","journal-title":"Front Pediatr"},{"issue":"3","key":"2025121807432071700_dgaf313-B33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000531766","article-title":"International guidelines for the diagnosis and management of hyperinsulinism","volume":"97","author":"De Leon","year":"2023","journal-title":"Horm Res Paediatr"},{"issue":"12","key":"2025121807432071700_dgaf313-B34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1515\/jpem-2023-0289","article-title":"The use of CGM to identify hypoglycemia and glycemic patterns in congenital hyperinsulinism","volume":"36","author":"Gariepy","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2025121807432071700_dgaf313-B35","author":"De"},{"issue":"9","key":"2025121807432071700_dgaf313-B36","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/dme.12247","article-title":"Hypoglycaemia, fear of hypoglycaemia and quality of life in children with type 1 diabetes and their parents","volume":"30","author":"Johnson","year":"2013","journal-title":"Diabet Med"},{"key":"2025121807432071700_dgaf313-B37","doi-asserted-by":"crossref","first-page":"1265076","DOI":"10.3389\/fendo.2023.1265076","article-title":"Accuracy and impact on quality of life of real-time continuous glucose monitoring in children with hyperinsulinaemic hypoglycaemia","volume":"14","author":"Sivasubramanian","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025121807432071700_dgaf313-B38","first-page":"100644","article-title":"Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: a cross-sectional population study of children with type 1 diabetes in New Zealand","volume":"31","author":"Burnside","year":"2023","journal-title":"Lancet Reg Health West Pac"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf313\/63356745\/dgaf313.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/139\/63356745\/dgaf313.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/111\/1\/139\/63356745\/dgaf313.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T12:44:47Z","timestamp":1766061887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/1\/139\/8149296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2025,12,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf313","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,5,26]]}}}